Amadeus Capital Partners, the global technology investor, has today announced an investment in Inotec AMD, a maker of mobile medical devices designed to heal chronic, hypoxic wounds that afflict ...
Treatment offers hope for patients with long-standing chronic wounds CAMBRIDGE, England, July 12, 2021 /PRNewswire/ -- Inotec AMD, manufacturer of NATROX® Oxygen Wound Therapy, is delighted to share ...